CVS Group plc (LON:CVSG) Stock Rated "Moderate Buy" by Wall Street Brokerages

Key Points

• CVS Group has a “Moderate Buy” consensus rating: Four of six covering analysts recommend buying the stock, while two rate it a hold. The average 12-month price target is GBX 1,666.67, above its reported opening price of GBX 1,285.
• CVS Group reported quarterly EPS of GBX 85.60, with analysts forecasting full-year EPS of GBX 93.94. The company posted a 2.43% net margin and 5.91% return on equity.
• Insiders have recently been buying shares, with 3,860 shares acquired over the past 90 days; insiders own 1.48% of the company. CVS operates more than 475 veterinary practices across the UK and Australia.

Shares of CVS Group plc (LON:CVSG - Get Free Report) have been assigned a consensus recommendation of "Moderate Buy" from the six ratings firms that are currently covering the company, MarketBeat Ratings reports. Two research analysts have rated the stock with a hold recommendation and four have issued a buy recommendation on the company. The average 12-month price objective among brokers that have updated their coverage on the stock in the last year is GBX 1,666.67.

Several equities research analysts have recently commented on the stock. Shore Capital Group reaffirmed a "hold" rating and set a GBX 1,400 price target on shares of CVS Group in a research report on Thursday, September 24th. Berenberg Bank reiterated a "buy" rating and issued a GBX 2,000 price objective on shares of CVS Group in a research note on Thursday, September 24th. Deutsche Bank Aktiengesellschaft reissued a "buy" rating and issued a GBX 1,700 price objective on shares of CVS Group in a report on Monday, July 27th. Finally, Jefferies Financial Group reissued a "hold" rating and issued a GBX 1,400 price objective on shares of CVS Group in a report on Friday, September 25th.

CVS Group Price Performance

CVSG stock opened at GBX 1,285 on Monday. CVS Group has a fifty-two week low of GBX 1,062 and a fifty-two week high of GBX 1,448. The business's 50-day moving average is GBX 1,267.36 and its two-hundred day moving average is GBX 1,229.18. The company has a debt-to-equity ratio of 110.41, a quick ratio of 0.90 and a current ratio of 1.18. The company has a market cap of £866.87 million, a price-to-earnings ratio of 52.88, a P/E/G ratio of 1.77 and a beta of 1.09.

CVS Group (LON:CVSG - Get Free Report) last announced its earnings results on Thursday, September 24th. The company reported GBX 85.60 earnings per share (EPS) for the quarter. CVS Group had a return on equity of 5.91% and a net margin of 2.43%. As a group, analysts forecast that CVS Group will post 93.94 earnings per share for the current year.

Insider Buying and Selling at CVS Group

In other CVS Group news, insider Joanne Shaw purchased 1,592 shares of the firm's stock in a transaction on Monday, August 10th. The shares were acquired at an average cost of GBX 1,287 per share, for a total transaction of £20,489.04. Also, insider Robin Alfonso purchased 768 shares of the firm's stock in a transaction on Thursday, August 6th. The stock was acquired at an average price of GBX 1,294 per share, for a total transaction of £9,937.92. Over the last ninety days, insiders acquired 3,860 shares of company stock valued at $4,956,696. Insiders own 1.48% of the company's stock.

CVS Group Company Profile

CVS Group is a leading provider of veterinary services, operating in the UK and Australia, listed on the Main Market of the London Stock Exchange. CVS is focused on providing high-quality clinical services to its clients and their animals, with outstanding and dedicated clinical teams and support colleagues at the core of its strategy. The Group operates from over 475 veterinary practices across its two territories, including specialist referral hospitals and dedicated out-of-hours sites. Alongside the core Veterinary Practices division, CVS operates Laboratories (providing diagnostic services to CVS and third-parties) and an online retail business ("Animed Direct"). The Group employs c.8,900 personnel, including c.2,400 veterinary surgeons and c.3,300 nurses.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.